VANGUARD GROUP INC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$1,070,329,787
-10.4%
39,437,354
+1.5%
0.03%
-7.1%
Q2 2023$1,194,181,249
-12.6%
38,847,796
+2.4%
0.03%
-20.0%
Q1 2023$1,366,618,585
-2.9%
37,930,019
+6.5%
0.04%
-7.9%
Q4 2022$1,408,010,301
+0.3%
35,627,791
+1.9%
0.04%
-7.3%
Q3 2022$1,404,364,000
+1.7%
34,951,810
+6.4%
0.04%
+5.1%
Q2 2022$1,381,172,000
+11.3%
32,853,776
+3.1%
0.04%
+34.5%
Q1 2022$1,241,289,000
+5.1%
31,860,621
+7.5%
0.03%
+7.4%
Q4 2021$1,181,017,000
+8.8%
29,636,565
-1.3%
0.03%0.0%
Q3 2021$1,085,216,000
+8.8%
30,028,062
+23.4%
0.03%
+8.0%
Q2 2021$997,787,000
+1.6%
24,342,200
+8.1%
0.02%
-7.4%
Q1 2021$981,999,000
+966.9%
22,512,593
+1124.2%
0.03%
+800.0%
Q4 2020$92,041,000
+54.8%
1,838,966
+30.2%
0.00%
+50.0%
Q3 2020$59,440,000
-11.5%
1,412,886
+2.1%
0.00%0.0%
Q2 2020$67,162,0001,383,3600.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2021
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$244,378,00079.54%
Vantage Consulting Group Inc 7,862,542$284,152,00060.85%
Memorial Sloan Kettering Cancer Center 2,680,644$96,878,00060.36%
Indie Asset Partners, LLC 701,323$25,346,00020.53%
HARVARD MANAGEMENT CO INC 7,142,856$258,143,00015.13%
Bleichroeder LP 1,115,980$40,332,0006.55%
Overbrook Management Corp 785,132$28,375,0006.16%
Geo Capital Gestora de Recursos Ltd 194,305$7,022,0003.21%
Brown University 621,759$22,470,0003.05%
Graypoint LLC 610,584$22,067,0002.71%
View complete list of ROYALTY PHARMA PLC shareholders